The 2009 Import and Export Market for Medicaments Containing Antibiotics or Their Derivatives in Oceana (Related Reports)

The 2009 Import and Export Market for Medicaments Containing Antibiotics or Their Derivatives in Oceana


May 16, 2009
27 Pages - SKU: ICN2315294
License type:
Online Download      US $325.00
Global Site License      US $650.00
Hepatitis Drugs Markets in China
4/16/2014 | published by: Asia Market Information & Development Company
Hepatitis Drugs Markets in China China's demand for hepatitis drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study  |  read more...
$4,000.00
Atomic Spectroscopy Market by Technology ( X-Ray Fluorescence / Atomic Absorption / X-Ray Diffraction / ICP-MS ) & by Application ( Food & Beverage / Pharmaceutical / Industrial Chemistry / Biotechnology / Environment ) - Competitive Landscape - Global Fo
4/14/2014 | published by: MarketsandMarkets
Atomic Spectroscopy Market by Technology ( X-Ray Fluorescence / Atomic Absorption / X-Ray Diffraction / ICP-MS ) & by Application ( Food & Beverage / Pharmaceutical / Industrial Chemistry / Biotechnology / Environment ) -  |  read more...
$4,650.00
Greece Pharmaceuticals and Healthcare Report Q2 2014
4/23/2014 | published by: Business Monitor International
Greece Pharmaceuticals and Healthcare Report Q2 2014 BMI View: Despite the Greek economy's expected return to growth in 2014, we expect no lessening in thepressures on the Greek pharmaceutical and healthcare sectors over the medium- to  |  read more...
$1,295.00
South Africa Pharmaceuticals and Healthcare Report Q2 2014
4/23/2014 | published by: Business Monitor International
South Africa Pharmaceuticals and Healthcare Report Q2 2014 BMI View: South Africa is the best investment opportunity for multinational drugmakers seeking to enterthe African market - boasting the largest medicines market on the continent and poised  |  read more...
$1,295.00
Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2014 BMI View: Low health and pharmaceutical expenditures will continue to limit the attractiveness of thepharmaceutical market in Cambodia. Given such a profile, the country will present more  |  read more...
$1,295.00
Bahrain Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Bahrain Pharmaceuticals and Healthcare Report Q2 2014 BMI View: This quarter has seen the beginning of a multi-phased plan by the National Health RegulatoryAuthority to significantly reduce medicine prices in the country, signalling a potential advancement  |  read more...
$1,295.00
Denmark Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Denmark Pharmaceuticals and Healthcare Report Q2 2014 BMI View: Although Denmark's pharmaceutical market is relatively small compared to other WesternEuropean countries, the demand for high quality healthcare will remain elevated by an increasing andageing population. This  |  read more...
$1,295.00
Iraq Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Iraq Pharmaceuticals and Healthcare Report Q2 2014 BMI View: The projected growth of Iraq's pharmaceutical market in 2014 and 2015 is linked to an oildriveneconomic expansion, which is dependent on the government's ability to represent and  |  read more...
$1,295.00
Lithuania Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Lithuania Pharmaceuticals and Healthcare Report Q2 2014 BMI View: We expect the Lithuanian pharmaceutical market to post a five-year compound annual growthrate (CAGR) of 4.4%, rising to a value of LTL2.16bn (US$751mn) in 2018. While double-digit  |  read more...
$1,295.00
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2014 BMI View: A better-than-expected outlook for Sri Lanka's economy has led us to upwardly revise ourpharmaceutical and healthcare forecasts. The government has introduced price controls on wholesale andretail  |  read more...
$1,295.00